Combined targeting of the epidermal growth factor receptor and cyclooxygenase-2 pathways

被引：43

作者：

Lippman, SM

Gibson, N

Subbaramaiah, K

Dannenberg, AJ

机构：

[1] Univ Texas, Dept Clin Canc Prevent, Unit 1360, MD Anderson Canc Ctr, Houston, TX 77230 USA

[2] Univ Texas, Dept Thorac Head & Neck Med Oncol, MD Anderson Canc Ctr, Houston, TX 77230 USA

[3] Cornell Univ, Weill Med Coll, Dept Med, New York, NY 10021 USA

[4] OSI Oncol, Farmingdale, NY USA

来源：

CLINICAL CANCER RESEARCH | 2005年 / 11卷 / 17期

关键词：

D O I：

10.1158/1078-0432.CCR-05-1217

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：6097 / 6099

页数：3

共 24 条

[1] The convergence of cancer prevention and therapy in early-phase clinical drug development [J].

Abbruzzese, JL ;

Lippman, SM .

CANCER CELL, 2004, 6 (04) :321-326

[2] 15-hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer [J].

Backlund, MG ;

Mann, JR ;

Holla, VR ;

Buchanan, FG ;

Tai, HH ;

Musiek, ES ;

Milne, GL ;

Katkuri, S ;

DuBois, RN .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (05) :3217-3223

[3] High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer [J].

Bremnes, RM ;

Veve, R ;

Gabrielson, E ;

Hirsch, FR ;

Baron, A ;

Bemis, L ;

Gemmill, RM ;

Drabkin, HA ;

Franklin, WA .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (10) :2417-2428

[4] Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor [J].

Buchanan, FG ;

Wang, DZ ;

Bargiacchi, F ;

DuBois, RN .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (37) :35451-35457

[5] Cyclooxygenase-2 and epidermal growth factor receptor: Pharmacologic targets for chemoprevention [J].

Dannenberg, AJ ;

Lippman, SM ;

Mann, JR ;

Subbaramaiah, K ;

DuBois, RN .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (02) :254-266

[6] Targeting cyclooxygenase-2 in human neoplasia: Rationale and promise [J].

Dannenberg, AJ ;

Subbaramaiah, K .

CANCER CELL, 2003, 4 (06) :431-436

[7] NAD+-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer [J].

Ding, YF ;

Tong, M ;

Liu, SQ ;

Moscow, JA ;

Tai, HH .

CARCINOGENESIS, 2005, 26 (01) :65-72

[8]

Dohadwala Mariam, 2005, Proceedings of the American Association for Cancer Research Annual Meeting, V46, P58

[9] Cytokeratin 20, AN43, PGDH, and COX-2 expression in transitional and squamous cell carcinoma of the bladder [J].

Gee, JR ;

Montoya, RG ;

Khaled, HM ;

Sabichi, AL ;

Grossman, HB .

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2003, 21 (04) :266-270

[10]

Griffin Graeme, 2005, Proceedings of the American Association for Cancer Research Annual Meeting, V46, P543

← 1 2 3 →